Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Richard C Malabre

Svp, Chief Accounting Officer at Akebia Therapeutics, Inc. (AKBA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $69K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 36,142312,772 held (−10%) $1.39 $50K -51.8%
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 13,382299,390 held (−4%) $1.39 $19K -51.8%
  • Sell

    Svp, Chief Accounting Officer Richard C Malabre sold $50K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp, Chief Accounting Officer Richard C Malabre sold $19K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.